Navigation Links
Cosmetic Eye Enhancer may Lead to Disfigurement

Polylactic acid (PLA), used as a cosmetic enhancement to decrease volume loss around the eyes, leads to disfigurement when not injected properly . The authors reviewed four cases where patients were injected superficially; all four exhibited nodule development and inflammation.

PLA should not be injected superficially, especially around the eyes, says study author and dermatologist Greg Goodman. This material does not act as a dermal filler, which would be injected superficially to smooth wrinkles, but needs to be placed deeply below the muscles to be a safer and more effective agent.

The technique is still so comparatively new and unproven, however, that Goodman cautions against its use around the eyes unless completed by a doctor who is experienced in its use.

According to Goodman, many cosmetic techniques are implemented too quickly and too carelessly. Practitioners should be wary of new procedures and instruction from representatives who themselves have been recently trained in the procedures, says Goodman.

Goodman also cautions patients against trying the newest products on the market. New procedures are not necessarily the best procedures; sometimes waiting for a procedure to improve and mature over many years is the best policy for those seeking safe, quality results.


'"/>




Page: 1

Related medicine news :

1. Cosmetic plastic surgery for a youthful healthy look
2. How Safe Are Your Cosmetics ?
3. “Yes, I need Cosmetic surgery” – view of majority wome
4. Details of Cosmetic Surgery in a Special Website.
5. More People Come To India For Cosmetic Surgery
6. Transparency in Probable Outcomes of Cosmetic Surgeries Necessary
7. Cosmetic Surgeons Discuss Facelift Surgery
8. Chemical Content in Cosmetic Products may be Harmful for Health
9. Campaign Against Cosmetic Surgeries Performed By Less-Skilled Non-physicians Launched
10. Survey Finds Americans Not Averse To Cosmetic Surgery
11. Do Anti-wrinkle Cosmetics Really Work?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... , ... June 27, 2016 ... ... the patient payment industry today announced its strategic partnership with Connance, a ... workflows. , The two companies’ proven, proprietary technology combine to provide health ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
Breaking Medicine Technology: